{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:50:30Z","timestamp":1789995030612,"version":"4.0.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T00:00:00Z","timestamp":1531267200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1245\/s10434-018-6621-4","type":"journal-article","created":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T16:59:59Z","timestamp":1531328399000},"page":"2925-2931","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Underdiagnosis of Hereditary Breast and Ovarian Cancer in Medicare Patients: Genetic Testing Criteria Miss the Mark"],"prefix":"10.1245","volume":"25","author":[{"given":"Shan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Axilbund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"O\u2019Leary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott T.","family":"Michalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robbie","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen E.","family":"Lincoln","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward D.","family":"Esplin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Nussbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,11]]},"reference":[{"key":"6621_CR1","unstructured":"American Cancer Society: Breast Cancer Facts & Figures\u00a02017\u20132018. American Cancer Society, Atlanta, GA. 2017. \n                    https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/breast-cancer-facts-and-figures\/breast-cancer-facts-and-figures-2017-2018.pdf\n                    \n                  . Accessed April 2018."},{"issue":"4","key":"6621_CR2","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1001\/jamaoncol.2015.5495","volume":"2","author":"BM Norquist","year":"2016","unstructured":"Norquist BM, Harrell MI, Brady MF, et al. Inherited mutations in women with ovarian carcinoma. JAMA Oncol. 2016;2(4):482\u201390.","journal-title":"JAMA Oncol."},{"issue":"6","key":"6621_CR3","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1245\/s10434-012-2257-y","volume":"19","author":"B Drohan","year":"2012","unstructured":"Drohan B, Roche CA, Cusack Jr JC, Hughes KS. Hereditary breast and ovarian cancer and other hereditary syndromes: using technology to identify carriers. Ann Surg Oncol. 2012;19(6):1732\u20137.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"6621_CR4","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1093\/jnci\/dju420","volume":"107","author":"E Levy-Lahad","year":"2015","unstructured":"Levy-Lahad E, Lahad A, King M-C. Precision medicine meets public health: population screening for BRCA1 and BRCA2. J Natl Cancer Inst. 2015;107(1):420.","journal-title":"J Natl Cancer Inst."},{"issue":"34","key":"6621_CR5","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.1200\/JCO.2017.73.6314","volume":"35","author":"CP Childers","year":"2017","unstructured":"Childers CP, Childers KK, Maggard-Gibbons M, Macinko J. National estimates of genetic testing in women with a history of breast or ovarian cancer. J Clin Oncol. 2017;35(34):3800\u20136.","journal-title":"J Clin Oncol."},{"issue":"6","key":"6621_CR6","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.amepre.2017.01.027","volume":"52","author":"F Guo","year":"2017","unstructured":"Guo F, Hirth JM, Lin Y-L, et al. Use of BRCA mutation test in the US, 2004\u20132014. Am J Prev Med. 2017;52(6):702\u20139.","journal-title":"Am J Prev Med."},{"issue":"1","key":"6621_CR7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10549-013-2583-1","volume":"140","author":"DGR Evans","year":"2013","unstructured":"Evans DGR, Ingham SL, Baildam A, et al. Contralateral mastectomy improves survival in women with BRCA1\/2-associated breast cancer. Breast Cancer Res Treat. 2013;140(1):135\u201342.","journal-title":"Breast Cancer Res Treat."},{"issue":"6","key":"6621_CR8","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1056\/NEJMoa1706450","volume":"377","author":"M Robson","year":"2017","unstructured":"Robson M, Im S-A, Senkus E, et al. Olaparib for metastatic breast cancer in patients with a germline BRCA mutation. N Engl J Med. 2017;377(6):523\u201333.","journal-title":"N Engl J Med."},{"key":"6621_CR9","unstructured":"Local coverage determination: MolDx BRCA1 and BRCA2 genetic testing. Noridian Medicare. \n                    https:\/\/med.noridianmedicare.com\/documents\/10546\/6990981\/MolDX+BRCA1+and+BRCA2+Genetic+Testing+LCD\/220c55c8-8bc8-4319-80a1-66c4a1d51dd8\n                    \n                  . Accessed April 2018."},{"issue":"10","key":"6621_CR10","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1245\/s10434-017-5963-7","volume":"24","author":"E O\u2019Leary","year":"2017","unstructured":"O\u2019Leary E, Iacoboni D, Holle J, et al. Expanded gene panel use for women with breast cancer: identification and intervention beyond breast cancer risk. Ann Surg Oncol. 2017;24(10):3060\u20136.","journal-title":"Ann Surg Oncol."},{"issue":"5","key":"6621_CR11","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jmoldx.2015.04.009","volume":"17","author":"SE Lincoln","year":"2015","unstructured":"Lincoln SE, Kobayashi Y, Anderson MJ, et al. A systematic comparison of traditional and multigene panel testing for hereditary breast and ovarian cancer genes in more than 1000 patients. J Mol Diagn. 2015;17(5):533\u201344.","journal-title":"J Mol Diagn."},{"key":"6621_CR12","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/gim.2017.37","volume":"19","author":"K Nykamp","year":"2017","unstructured":"Nykamp K, Anderson M, Powers M, et al. Sherloc: a comprehensive refinement of the ACMG\u2013AMP variant classification criteria. Genet Med. 2017;19:1105.","journal-title":"Genet Med."},{"issue":"1","key":"6621_CR13","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1186\/s12885-017-3422-2","volume":"17","author":"EM Grindedal","year":"2017","unstructured":"Grindedal EM, Heramb C, Karsrud I, et al. Current guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriers. BMC Cancer. 2017;17(1):438.","journal-title":"BMC Cancer."},{"issue":"13","key":"6621_CR14","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1200\/JCO.2015.65.0747","volume":"34","author":"N Tung","year":"2016","unstructured":"Tung N, Lin NU, Kidd J, et al. Frequency of germline mutations in 25 cancer-susceptibility genes in a sequential series of patients with breast cancer. J Clin Oncol. 2016;34(13):1460\u20138.","journal-title":"J Clin Oncol."},{"issue":"1","key":"6621_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/cncr.29010","volume":"121","author":"N Tung","year":"2015","unstructured":"Tung N, Battelli C, Allen B, et al. Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel. Cancer. 2015;121(1):25\u201333.","journal-title":"Cancer."},{"issue":"7","key":"6621_CR16","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1001\/jamaoncol.2015.2690","volume":"1","author":"A Desmond","year":"2015","unstructured":"Desmond A, Kurian AW, Gabree M, et al. Clinical actionability of multigene panel testing for hereditary breast and ovarian cancer risk assessment. JAMA Oncol. 2015;1(7):943\u201351.","journal-title":"JAMA Oncol."},{"issue":"4","key":"6621_CR17","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/cam4.1376","volume":"7","author":"J Hauke","year":"2018","unstructured":"Hauke J, Horvath J, Gro\u00df E, et al. Gene panel testing of 5589 BRCA1\/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer. Cancer Med. 2018;7(4):1349\u201358.","journal-title":"Cancer Med."},{"issue":"6","key":"6621_CR18","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1086\/421251","volume":"74","author":"CHEK2 Breast Cancer Case-Control Consortium","year":"2004","unstructured":"CHEK2 Breast Cancer Case-Control Consortium. CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9065 controls from 10 studies. Am J Hum Genet. 2004;74(6):1175\u201382.","journal-title":"Am J Hum Genet."},{"issue":"11","key":"6621_CR19","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","volume":"25","author":"S Chen","year":"2007","unstructured":"Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol. 2007;25(11):1329\u201333.","journal-title":"J Clin Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-018-6621-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-018-6621-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-018-6621-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T23:03:23Z","timestamp":1562799803000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-018-6621-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,11]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["6621"],"URL":"https:\/\/doi.org\/10.1245\/s10434-018-6621-4","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,11]]},"assertion":[{"value":"23 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}